Evermay Wealth Management LLC Acquires 50 Shares of CME Group Inc. $CME

Evermay Wealth Management LLC increased its holdings in shares of CME Group Inc. (NASDAQ:CME) by 14.3% during the second quarter, Holdings Channel.com reports. The fund owned 400 shares of the financial services provider’s stock after purchasing an additional 50 shares during the quarter. Evermay Wealth Management LLC’s holdings in CME Group were worth $110,000 as of its most recent filing with the SEC.

Other hedge funds have also bought and sold shares of the company. Wayfinding Financial LLC bought a new position in CME Group during the first quarter worth about $25,000. Webster Bank N. A. increased its position in CME Group by 206.9% during the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock worth $25,000 after acquiring an additional 60 shares during the period. Cornerstone Planning Group LLC increased its position in CME Group by 122.2% during the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 55 shares during the period. Highline Wealth Partners LLC increased its position in CME Group by 84.3% during the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 43 shares during the period. Finally, Golden State Wealth Management LLC increased its position in CME Group by 612.5% during the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider’s stock worth $30,000 after acquiring an additional 98 shares during the period. 87.75% of the stock is owned by institutional investors.

CME Group Trading Down 0.1%

Shares of CME Group stock opened at $267.62 on Tuesday. The firm has a market capitalization of $96.44 billion, a PE ratio of 25.91, a price-to-earnings-growth ratio of 6.16 and a beta of 0.41. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The firm’s 50 day moving average is $266.94 and its 200 day moving average is $271.50. CME Group Inc. has a 1 year low of $213.94 and a 1 year high of $290.79.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping the consensus estimate of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The business had revenue of $1.69 billion for the quarter, compared to the consensus estimate of $1.68 billion. During the same period last year, the company earned $2.56 EPS. The firm’s revenue was up 10.4% compared to the same quarter last year. Equities research analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were given a dividend of $1.25 per share. The ex-dividend date was Tuesday, September 9th. This represents a $5.00 annualized dividend and a yield of 1.9%. CME Group’s dividend payout ratio (DPR) is currently 48.40%.

Insider Buying and Selling at CME Group

In other news, General Counsel Jonathan L. Marcus sold 392 shares of the company’s stock in a transaction on Thursday, September 18th. The shares were sold at an average price of $262.00, for a total value of $102,704.00. Following the sale, the general counsel directly owned 7,851 shares of the company’s stock, valued at approximately $2,056,962. This represents a 4.76% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Timothy Francis Mccourt sold 379 shares of the company’s stock in a transaction on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total transaction of $98,475.57. Following the completion of the sale, the insider directly owned 9,508 shares in the company, valued at approximately $2,470,463.64. This represents a 3.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 13,043 shares of company stock valued at $3,527,956 in the last quarter. 0.30% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several equities analysts have commented on CME shares. Deutsche Bank Aktiengesellschaft decreased their target price on shares of CME Group from $276.00 to $266.00 and set a “hold” rating on the stock in a report on Thursday, October 9th. Keefe, Bruyette & Woods raised their target price on shares of CME Group from $283.00 to $287.00 and gave the company a “market perform” rating in a report on Monday, October 13th. Jefferies Financial Group decreased their target price on shares of CME Group from $313.00 to $304.00 and set a “buy” rating on the stock in a report on Friday, October 10th. Oppenheimer raised their target price on shares of CME Group from $300.00 to $303.00 and gave the company an “outperform” rating in a report on Thursday, July 24th. Finally, Morgan Stanley raised their target price on shares of CME Group from $303.00 to $312.00 and gave the company an “overweight” rating in a report on Wednesday, October 1st. Seven analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $283.71.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.